Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 2Thoracic Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Neoplasms by Site 1Neoplasms 1Lung Diseases 1

Interventions

padeliporfin 5Nivolumab 3entrectinib 2cobimetinib 2capmatinib 2atezolizumab 2anlotinib 2alectinib 2Vemurafenib 2Sunitinib 2Radiosurgery 2Cyclophosphamide 2Cisplatin 2Aspirin 2Ascorbic Acid 2trametinib 1spartalizumab 1relatlimab 1pertuzumab 1pembrolizumab 1palladium-bacteriopheophorbide 1olaparib 1niraparib 1nintedanib 1montanide ISA 51 1lutetium Lu 177 dotatate 1guadecitabine 1genexol-PM 1durvalumab 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms by Site × Telescopes × Clear all
NCT07165691 2025-12-02

TELESCOPE-H

Rutgers, The State University of New Jersey

Phase NA Recruiting
91 enrolled
Thoracic

Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡